Rea Kuehl1,2, Martina E Schmidt2, Peter Dreger3, Karen Steindorf2, Martin Bohus4,5, Joachim Wiskemann6,7. 1. Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. 2. Department of Preventive Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. 3. Department of Medicine V, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. 4. Department of Psychiatric and Psychosomatics Psychotherapy, Central Institute of Mental Health, J5, 68159, Mannheim, Germany. 5. Faculty of Health, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium. 6. Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. joachim.wiskemann@nct-heidelberg.de. 7. Department of Preventive Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. joachim.wiskemann@nct-heidelberg.de.
Abstract
BACKGROUND: Evidence from randomized controlled trials is growing that exercise interventions are beneficial in cancer patients receiving allogeneic stem cell transplantation (allo-HCT). However, information about adherence to exercise interventions and exercise contamination in control groups is lacking. This information is crucial for the interpretation of study results. We therefore examined the determinants of exercise adherence and contamination in different treatment periods during (inpatient) and after (outpatient) allo-HCT. METHODS:One hundred fifty-three patients scheduled for allo-HCT were randomized to a 1-year partly supervised exercise intervention (endurance and resistance exercise) or to a control group. Adherence was assessed via exercise logs and contamination via questionnaires. RESULTS:Adherence varied between 66 % (inpatient) and 78 % (outpatient) in different treatment periods. During (inpatient) transplantation period, higher adherence was significantly associated with lower fatigue (P = 0.004) and with having children at home (P = 0.049). Adherence after discharge was positively associated with endurance performance (P = 0.003); higher adherence after day 100 was associated with exercise activity prior allo-HCT (P = 0.010) and higher adherence after discharge (P = 0.001). Contamination among controls was high with 54 % and significantly associated with muscle strength (P = 0.025) and fatigue (P = 0.050). CONCLUSION:Exercise adherence in different treatment periods was determined by different variables, and contamination among controls was evident. These findings may have important implications for correct interpretation of randomized exercise intervention trials.
RCT Entities:
BACKGROUND: Evidence from randomized controlled trials is growing that exercise interventions are beneficial in cancerpatients receiving allogeneic stem cell transplantation (allo-HCT). However, information about adherence to exercise interventions and exercise contamination in control groups is lacking. This information is crucial for the interpretation of study results. We therefore examined the determinants of exercise adherence and contamination in different treatment periods during (inpatient) and after (outpatient) allo-HCT. METHODS: One hundred fifty-three patients scheduled for allo-HCT were randomized to a 1-year partly supervised exercise intervention (endurance and resistance exercise) or to a control group. Adherence was assessed via exercise logs and contamination via questionnaires. RESULTS: Adherence varied between 66 % (inpatient) and 78 % (outpatient) in different treatment periods. During (inpatient) transplantation period, higher adherence was significantly associated with lower fatigue (P = 0.004) and with having children at home (P = 0.049). Adherence after discharge was positively associated with endurance performance (P = 0.003); higher adherence after day 100 was associated with exercise activity prior allo-HCT (P = 0.010) and higher adherence after discharge (P = 0.001). Contamination among controls was high with 54 % and significantly associated with muscle strength (P = 0.025) and fatigue (P = 0.050). CONCLUSION: Exercise adherence in different treatment periods was determined by different variables, and contamination among controls was evident. These findings may have important implications for correct interpretation of randomized exercise intervention trials.
Authors: Clare Stevinson; Katia Tonkin; Valerie Capstick; Alexandra Schepansky; Aliya B Ladha; Jeffrey K Valance; Wylam Faught; Helen Steed; Kerry S Courneya Journal: J Phys Act Health Date: 2009-05
Authors: J Wiskemann; R Kuehl; P Dreger; R Schwerdtfeger; G Huber; C M Ulrich; D Jaeger; M Bohus Journal: Bone Marrow Transplant Date: 2013-12-09 Impact factor: 5.483
Authors: Julienne E Bower; Kate Bak; Ann Berger; William Breitbart; Carmelita P Escalante; Patricia A Ganz; Hester Hill Schnipper; Christina Lacchetti; Jennifer A Ligibel; Gary H Lyman; Mohammed S Ogaily; William F Pirl; Paul B Jacobsen Journal: J Clin Oncol Date: 2014-04-14 Impact factor: 44.544
Authors: Caroline S Kampshoff; Femke Jansen; Willem van Mechelen; Anne M May; Johannes Brug; Mai J M Chinapaw; Laurien M Buffart Journal: Int J Behav Nutr Phys Act Date: 2014-07-02 Impact factor: 6.457
Authors: Ruud H Knols; Geert Aufdemkampe; Eling D de Bruin; Daniel Uebelhart; Neil K Aaronson Journal: BMC Musculoskelet Disord Date: 2009-03-09 Impact factor: 2.362
Authors: J R Passweg; H Baldomero; M Bregni; S Cesaro; P Dreger; R F Duarte; J H F Falkenburg; N Kröger; D Farge-Bancel; H Bobby Gaspar; J Marsh; M Mohty; C Peters; A Sureda; A Velardi; C Ruiz de Elvira; A Madrigal Journal: Bone Marrow Transplant Date: 2013-04-15 Impact factor: 5.483
Authors: Michael Mendes Wefelnberg; Timo Niels; Udo Holtick; Franziska Jundt; Christoph Scheid; Freerk T Baumann Journal: Support Care Cancer Date: 2022-10-03 Impact factor: 3.359
Authors: Matthias Limbach; Rea Kuehl; Peter Dreger; Thomas Luft; Friederike Rosenberger; Nikolaus Kleindienst; Birgit Friedmann-Bette; Andrea Bondong; Martin Bohus; Joachim Wiskemann Journal: Support Care Cancer Date: 2020-05-04 Impact factor: 3.603
Authors: Saskia Persoon; Mai J M ChinAPaw; Laurien M Buffart; Roberto D K Liu; Pierre Wijermans; Harry R Koene; Monique C Minnema; Pieternella J Lugtenburg; Erik W A Marijt; Johannes Brug; Frans Nollet; Marie José Kersten Journal: PLoS One Date: 2017-07-20 Impact factor: 3.240
Authors: Dieter Lemke; Hans-Werner Pledl; Markus Zorn; Manfred Jugold; Ed Green; Jonas Blaes; Sarah Löw; Anne Hertenstein; Martina Ott; Felix Sahm; Ann-Catherine Steffen; Markus Weiler; Frank Winkler; Michael Platten; Zhen Dong; Wolfgang Wick Journal: Oncotarget Date: 2016-08-30
Authors: H L Ormel; G G F van der Schoot; W J Sluiter; M Jalving; J A Gietema; A M E Walenkamp Journal: Psychooncology Date: 2018-01-26 Impact factor: 3.894
Authors: Daniel Santa Mina; Lianne B Dolan; Jeffrey H Lipton; Darren Au; Encarna Camacho Pérez; Alyssa Franzese; Shabbir M H Alibhai; Jennifer M Jones; Eugene Chang Journal: J Clin Med Date: 2020-06-14 Impact factor: 4.241